CATHERINE BLYTH: Open Payments
NPI 1013461763 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 26 payments from 15 companies in 2025. Trend: 2023 $352 · 2024 $449 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $88 |
| Lundbeck LLC | 4 | $81 |
| Astellas Pharma US Inc | 2 | $46 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Amgen Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| ABBVIE INC. | 2 | $33 |
| Radius Health, Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $19 |
Products named: AUSTEDO XR, REXULTI, Veozah, INGREZZA, Auvelity, EVENITY, CAPLYTA, Tymlos.
Industry payments across IN — which companies pay providers there.
